Vna Health Care An Illinois Not For Profit Corp 400 North Highland Avenue, Aurora, IL, 60506 | |
(630) 978-2532 |
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
Name | Vna Health Care An Illinois Not For Profit Corp |
---|---|
Location | 400 North Highland Avenue, Aurora, Illinois |
Hospice ID | 141553 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 530 |
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
NPI Number | 1477677565 |
Organization Name | Vna Health Care |
Address | 400 N Highland Ave Aurora, Illinois, 60506 |
Phone Number | (630)978-2532 |
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
NPI Number | 1508826983 |
Organization Name | Vna Health Care |
Address | 400 N Highland Ave Aurora, Illinois, 60506 |
Phone Number | (630)978-2532 |
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
Home Health Aides | 0.04 |
Counselors | 0.01 |
Homemakers | 0.04 |
Medical Social Workers | 0.01 |
Physicians | 0.01 |
Registered Nurses | 0.1 |
Total Employees | 0.21 |
---|
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
Others | 0.02 |
Total Volunteers | 0.02 |
---|
News Archive
Kaiser Foundation Health Plan on Tuesday announced that it is working with California insurance regulators to develop new guidelines for canceling individual policyholders' coverage, the Los Angeles Times reports.
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
A case involving seven transplant recipients killed by a rodent-borne virus that they apparently acquired from donated and infected human organs has prompted a recommendation that regulatory authorities require suppliers of pet rodents to screen their colonies for the virus.
› Verified 4 days ago
Vna Health Care An Illinois Not For Profit Corp Location: 400 North Highland Avenue, Aurora, Illinois, 60506 Phone: (630) 978-2532 |